{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:49:13Z","timestamp":1783774153303,"version":"3.55.0"},"reference-count":32,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>Flow-diverting stents offer a novel treatment approach to intracranial aneurysms. Data regarding the incidence of acute procedure-related thromboembolic complications following deployment of the Pipeline Embolization Device (PED) remain scant. The authors sought to determine the rate of embolic events in a bid to identify potential risk factors and assess the role of platelet inhibition.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Data in all patients receiving a PED for treatment of an intracranial aneurysm were prospectively maintained in a database. Diffusion-weighted 3-T MRI was performed within 24 hours of PED deployment. The incident rate of procedural embolism was established, and univariate analysis was then performed to determine any associations of embolic events with measured variables. The degree of platelet inhibition in response to aspirin and clopidogrel was evaluated by challenging the platelet samples with arachidonic acid and adenosine diphosphate, respectively, and then performing formal light transmission platelet aggregometry.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Twenty-three patients with 26 aneurysms were eligible for inclusion in the study. Thirty-one PEDs were deployed in 25 procedures. All ischemic lesions detected on diffusion-weighted 3-T MRI were identified as embolic based on their location and distribution, with none appearing to be due to perforator artery occlusion. Procedural embolic events were found in the target parent vessel territory in 13 (52%) of 25 procedures, with no patients harboring lesions contralateral to the deployed PED. The number of embolic events per procedure ranged from 3 to 16, with a mean of 5.4. There was no significant difference between cases with and without procedural embolism in platelet inhibition by aspirin (mean 15% vs 12% residual activation; p = 0.28), platelet inhibition by clopidogrel (mean 41% vs 41% residual activation; p = 0.98), or intraprocedural heparin-induced anticoagulation (mean activated clotting time 235 seconds vs 237 seconds; p = 0.81). By multivariate analysis, the authors identified larger aneurysm size (p = 0.03) as the single variable significantly associated with procedural embolism. There was no significant relationship between aneurysm size and the number of embolic events (p = 0.32) or the total burden of the embolism lesion area (p = 0.53).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Acute embolism following use of the PED for treatment of intracranial aneurysms is more common than hypothesized. The only identifiable risk factor for embolism appears to be greater aneurysm size, perhaps indicating significant disturbed flow across the aneurysm neck with ingress and egress through the PED struts. The strength of antiplatelet therapy, as measured by residual platelet aggregation, did not appear to be associated with cases of procedural embolism. Further work is needed to determine the implications of these findings and whether anticoagulation regimens can be altered to lower the rate of complications following PED deployment.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2013.7.jns122178","type":"journal-article","created":{"date-parts":[[2013,8,23]],"date-time":"2013-08-23T14:04:51Z","timestamp":1377266691000},"page":"1603-1610","source":"Crossref","is-referenced-by-count":58,"title":["Effect of antiplatelet therapy on thromboembolism after flow diversion with the Pipeline Embolization Device"],"prefix":"10.3171","volume":"119","author":[{"given":"Robert S.","family":"Heller","sequence":"first","affiliation":[{"name":"Cerebrovascular and Endovascular Division, Department of Neurosurgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Dandamudi","sequence":"additional","affiliation":[{"name":"Cerebrovascular and Endovascular Division, Department of Neurosurgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lanfranchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adel M.","family":"Malek","sequence":"additional","affiliation":[{"name":"Cerebrovascular and Endovascular Division, Department of Neurosurgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns122178","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/S0140-6736(99)07083-X","article-title":"Silent embolism in diagnostic cerebral angiography and neurointerventional procedures: a prospective study","volume":"354","author":"Bendszus","year":"1999"},{"key":"b2-jns122178","series-title":"Platelets","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/09537100903437206","article-title":"VerifyNow and VASP phosphorylation assays give similar results for patients receiving clopidogrel, but they do not always correlate with platelet aggregation","volume":"21","author":"Bidet","year":"2010"},{"key":"b3-jns122178","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1160\/TH09-02-0126","article-title":"Response to aspirin in healthy individuals. Crosscomparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)","volume":"102","author":"Blais","year":"2009"},{"key":"b4-jns122178","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010"},{"key":"b5-jns122178","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00234-012-1047-3","article-title":"Italian multicenter experience with flow-diverter devices for intracranial unruptured aneurysm treatment with periprocedural complications\u2014a retrospective data analysis","volume":"54","author":"Briganti","year":"2012"},{"key":"b6-jns122178","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/STROKEAHA.111.620328","article-title":"Flow diversion for intracranial aneurysms: a review","volume":"42","author":"D'Urso","year":"2011"},{"key":"b7-jns122178","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1160\/TH08-01-0049","article-title":"Clinical implications of clopidogrel resistance","volume":"100","author":"De Miguel","year":"2008"},{"key":"b8-jns122178","series-title":"J Neurointerv Surg","article-title":"Pre-procedure P2Y12 reaction units value predicts perioperative thromboembolic and hemorrhagic complications in patients with cerebral aneurysms treated with the Pipeline Embolization Device","author":"Delgado Almandoz","year":"2013"},{"key":"b9-jns122178","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1227\/01.NEU.0000313128.12325.14","article-title":"Definitive reconstruction of circumferential, fusiform intracranial aneurysms with the pipeline embolization device","volume":"62","author":"Fiorella","year":"2008"},{"key":"b10-jns122178","series-title":"Neuroradiology","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00234-011-0948-x","article-title":"Pipeline embolization device (PED) for neurovascular reconstruction: initial experience in the treatment of 101 intracranial aneurysms and dissections","volume":"54","author":"Fischer","year":"2012"},{"key":"b11-jns122178","series-title":"J Interv Cardiol","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1540-8183.2011.00670.x","article-title":"Correlation between light transmission aggregometry, VerifyNow P2Y12, and VASP-P platelet reactivity assays following percutaneous coronary intervention","volume":"24","author":"Gaglia","year":"2011"},{"key":"b12-jns122178","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1160\/TH09-08-0527","article-title":"A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease","volume":"103","author":"Grove","year":"2010"},{"key":"b13-jns122178","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3171\/2011.4.JNS102050","article-title":"Crescent sign on magnetic resonance angiography revealing incomplete stent apposition: correlation with diffusion-weighted changes in stent-mediated coil embolization of aneurysms. Clinical article","volume":"115","author":"Heller","year":"2011"},{"key":"b14-jns122178","series-title":"J Cardiovasc Pharmacol","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/FJC.0b013e3181dd0ec2","article-title":"A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis","volume":"56","author":"Jakubowski","year":"2010"},{"key":"b15-jns122178","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1161\/STROKEAHA.106.479576","article-title":"A new endoluminal, flow-disrupting device for treatment of saccular aneurysms","volume":"38","author":"Kallmes","year":"2007"},{"key":"b16-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3174\/ajnr.A1530","article-title":"A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms","volume":"30","author":"Kallmes","year":"2009"},{"key":"b17-jns122178","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1227\/NEU.0b013e31827060d9","article-title":"Early postmarket results after treatment of intracranial aneurysms with the pipeline embolization device: a U.S. multicenter experience","volume":"71","author":"Kan","year":"2012"},{"key":"b18-jns122178","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1227\/01.NEU.0000339109.98070.65","article-title":"Curative endovascular reconstruction of cerebral aneurysms with the pipeline embolization device: the Buenos Aires experience","volume":"64","author":"Lylyk","year":"2009"},{"key":"b19-jns122178","series-title":"Clin Chem","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1373\/clinchem.2009.137471","article-title":"Long-term aspirin and clopidogrel response evaluated by light transmission aggregometry, VerifyNow, and thrombelastography in patients undergoing percutaneous coronary intervention","volume":"56","author":"Madsen","year":"2010"},{"key":"b20-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3174\/ajnr.A2727","article-title":"Immediate and midterm results following treatment of unruptured intracranial aneurysms with the pipeline embolization device","volume":"33","author":"McAuliffe","year":"2012"},{"key":"b21-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3174\/ajnr.A2421","article-title":"The pipeline embolization device for the intracranial treatment of aneurysms trial","volume":"32","author":"Nelson","year":"2011"},{"key":"b22-jns122178","series-title":"Nat Med","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nm.1955","article-title":"A shear gradient-dependent platelet aggregation mechanism drives thrombus formation","volume":"15","author":"Nesbitt","year":"2009"},{"key":"b23-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3174\/ajnr.A3166","article-title":"Safety of the pipeline embolization device in treatment of posterior circulation aneurysms","volume":"33","author":"Phillips","year":"2012"},{"key":"b24-jns122178","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard-vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011"},{"key":"b25-jns122178","series-title":"Eur Heart J","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008"},{"key":"b26-jns122178","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3171\/2011.11.JNS111612","article-title":"Patency of the ophthalmic artery after flow diversion treatment of paraclinoid aneurysms. Clinical article","volume":"116","author":"Puffer","year":"2012"},{"key":"b27-jns122178","series-title":"J Neurointerv Surg","article-title":"Intra-aneurysmal hemodynamic alterations by a self-expandable intracranial stent and flow diversion stent: high intra-aneurysmal pressure remains regardless of flow velocity reduction","author":"Shobayashi","year":"2012"},{"key":"b28-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3174\/ajnr.A2023","article-title":"Treatment of intracranial aneurysms by functional reconstruction of the parent artery: the Budapest experience with the pipeline embolization device","volume":"31","author":"Szikora","year":"2010"},{"key":"b29-jns122178","series-title":"AJNR Am J Neuroradiol","doi-asserted-by":"publisher","first-page":"E43","DOI":"10.3174\/ajnr.A2034","article-title":"Perforator infarction after placement of a pipeline flow-diverting stent for an unruptured A1 aneurysm","volume":"31","author":"van Rooij","year":"2010"},{"key":"b30-jns122178","series-title":"J Neurointerv Surg","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1136\/neurintsurg-2011-010129","article-title":"Delayed intraparenchymal hemorrhage following pipeline embolization device treatment for a giant recanalized ophthalmic aneurysm","volume":"4","author":"Velat","year":"2012"},{"key":"b31-jns122178","series-title":"Korean J Lab Med","first-page":"460","article-title":"Determination of the prevalence of aspirin and clopidogrel resistances in patients with coronary artery disease by using various platelet-function tests","volume":"30","author":"Woo","year":"2010"},{"key":"b32-jns122178","series-title":"Thromb Haemost","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1160\/TH08-01-0056","article-title":"Clinical implications of aspirin resistance","volume":"100","author":"Zimmermann","year":"2008"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/6\/article-p1603.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/6\/article-p1603.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/6\/article-p1603.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:11:39Z","timestamp":1660497099000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/6\/article-p1603.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":32,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.3171\/2013.7.jns122178","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}